Higher iNGR uptake of the HT1080 cells—experienced at every investigated time point of the cell binding assay where the mechanism of NRP-1 could be expressed—indicates the better tumour-homing ability of the internalising peptide compared to the NGR counterpart. This evidence concerns the gene RTN4R and neoplasm.